---
figid: PMC2774770__nihms153556f1
figtitle: IL-4 induces an alternate pathway for BCR signalling
organisms:
- NA
pmcid: PMC2774770
filename: nihms153556f1.jpg
figlink: /pmc/articles/PMC2774770/figure/F1/
number: F1
caption: IL-4 induces an alternate pathway for BCR signalling. Some elements involved
  in mediating BCR-triggered intracellular signalling are shown. Mediators grouped
  together as the signalosome (PI-3K, Btk, BLNK, PLCγ2, and PKCβ) are indicated by
  the shaded region. B cell treatment with IL-4 produces an alternate pathway for
  BCR signalling, shown as a green arrow, that bypasses the need for multiple signalosome
  elements to bring about the downstream event of ERK phosphorylation, which is dependent
  on MEK activation here as in the classical pathway for BCR signalling. However,
  IL-4 treatment does not alter the requirement of signalosome mediators for BCR-triggered
  NF-κB activation. IL-4 induction of the alternate pathway for BCR signalling to
  pERK requires time and protein synthesis.
papertitle: 'Receptor crosstalk: reprogramming B cell receptor signalling to an alternate
  pathway results in expression and secretion of the autoimmunity-associated cytokine,
  osteopontin.'
reftext: T. L. Rothstein, et al. J Intern Med. ;265(6):632-643.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8707933
figid_alias: PMC2774770__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC2774770__F1
ndex: ee3dfec2-df1c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2774770__nihms153556f1.html
  '@type': Dataset
  description: IL-4 induces an alternate pathway for BCR signalling. Some elements
    involved in mediating BCR-triggered intracellular signalling are shown. Mediators
    grouped together as the signalosome (PI-3K, Btk, BLNK, PLCγ2, and PKCβ) are indicated
    by the shaded region. B cell treatment with IL-4 produces an alternate pathway
    for BCR signalling, shown as a green arrow, that bypasses the need for multiple
    signalosome elements to bring about the downstream event of ERK phosphorylation,
    which is dependent on MEK activation here as in the classical pathway for BCR
    signalling. However, IL-4 treatment does not alter the requirement of signalosome
    mediators for BCR-triggered NF-κB activation. IL-4 induction of the alternate
    pathway for BCR signalling to pERK requires time and protein synthesis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD79A
  - LYN
  - SYK
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - INPP5D
  - BTK
  - PLCG1
  - PLCG2
  - BLNK
  - PDK1
  - PDPK1
  - DAPP1
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - AKT1
  - AKT2
  - AKT3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - VAV1
  - VAV2
  - VAV3
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - BAD
  - CASP9
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - KRAS
  - HRAS
  - NRAS
  - CARD11
  - BCL10
  - MALT1
  - MAP3K1
  - RAF1
  - RNASE3
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IKBKB
  - CHUK
  - IKBKG
  - IKBKE
  - TBK1
  - AP2B1
  - AP2M1
  - AP2S1
  - AP3B1
  - AP3D1
  - AP3S1
  - AP3S2
  - AP1B1
  - AP1G1
  - AP1M1
  - AP1M2
  - AP1S1
  - AP1S2
  - AP1S3
  - AP4B1
  - AP4E1
  - AP4M1
  - AP4S1
  - AP5Z1
  - AP5B1
  - AP5M1
  - AP5S1
  - AP2A1
  - AP2A2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - PPARD
  - EPHB1
  - KCNH8
  - OGDH
  - JUN
  - JUNB
  - JUND
  - ATF2
  - GDNF
  - NFKB1
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - Guanine
  - Cancer
  - Noonan syndrome
---
